DNA gene vaccination for HIV

Springer Seminars in Immunopathology

Volumn 19, Issue 2, 1997, Pages 175-194

  Kim, Jong J ^a,b   Weiner, David B ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

GENE TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS GENOME;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; ANTIBODY FORMATION; ANTIGENIC VARIATION; CLINICAL TRIALS; CYTOKINES; GENOME, VIRAL; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; PRIMATES; RODENTIA; T-LYMPHOCYTE SUBSETS; VACCINATION; VACCINES, DNA; VIRAL PROTEINS;

EID: 0030663129     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00870267     Document Type: Review

References (117)

1. Akridge RE, Oyafuso LK, Reed SG (1994) IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol 153:5782
2. Arend WP, Dayer JM (1995) Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis Rheum 38:151
3. Ayyavoo V, Nagashunmugam T, Boyer JD, Sundarasamy M, Fernandes LS, Lee P, Lin J, Nguyen C, Chattergoon MA, Goedert JJ, Friedman H, Weiner DB (1997) Development of genetic vaccines for pathogenic genes: construction of attenuated Vif DNA immunization cassettes (in press)
4. Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, Somoza C (1993) B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76
5. Barrett N, Eder G, Dorner F (1991) Characterization of a vaccinia-derived recombinant HIV-1 gp160 candidate vaccine and its immunogenicity in chimpanzees. Biotech Therapeut 2:91
6. Berman P, Gregory TJ, Riddle L, Nakamura GR, Champe MA, Porter JP, Wurm FM, Hershberg RD, Cobb EK, Eichberg JW (1990) Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 345:622
7. Bertolini JN, Bertolini J, Thean E, Benson EM (1992) Human low molecular weight B cell growth factor induces surface IgM+/A- B cells to express and secrete IgA. J Immunol 149:1771
8. Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, Ulevitch R, Cerami A (1985) Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316:552
9. Blom M, Tool AT, Kok PT, Koenderman L, Roos D, Verhoeven AJ (1994) Granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 greatly enhance the interaction of human eosinophils with opsonized particles by changing the affinity of complement receptor type 3. Blood 83:2978
10. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type-1 infection. J Virol 68:6103
11. Boyer J, Wang B, Ugen KE, Srikantan V, Gilbert L, Kudchokar S, Javadian MA, Dang K, Merva M, Newman M, Carrano R, Coney L, Weiner DB (1995) Induction of humoral and cellular immune responses to HIV-1 in cynomologus Macaques and chimpanzees by in vivo DNA inoculation. In: Brown F, Chanock RM, Ginsberg HS, Norrby E (eds) Vaccines 95: Molecular approaches to the control of infectious diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
12. Boyer J, Wang B, Ugen K, Agadjanyan MG, Javadian MA, Frost P, Dang K, Carrano R, Ciccarelli R, Coney L, Williams WV, Weiner DB (1996) In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol 25:242
13. Boyer JD, Wang B, Ugen K, Agadjanyan MG, Javadian MA, Frost P, Dang K, Carrano R, Ciccarelli R, Coney L, Williams WV, Weiner DB (1996) Protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol 25:242
14. Boyer JD, Ugen KE, Wang B, Agadjanyan MG, Gilbert L, Bagarazzi M, Chattergoon M, Frost P, Javadian A, Williams WV, Refaeli Y, Ciccarelli RB, McCallus D, Coney L, Weiner DB (1997) Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Med (in press)
15. Brodsky FM, Guagliardi LE (1991) The cell biology of antigen processing and presentation. Annu Rev Immunol 9:707
16. Bruck C, Thiriart C, Delers A, et al (1993) Comparison of vaccine protection in chimpanzees immunized with two different forms of recombinant HIV-1 envelope glycoprotein. AIDS Res Hum Retroviruses 9:S110
17. Bruck C, Thiriart C, Fabry L, et al (1993) HIV-1 envelope elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. J Cell Biochem 17:88
18. Burton JD, Bramford RN, Peters C, Grant AJ, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA (1994) A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci USA 91:4935
19. Cao Y, Qin L, Zhang L, Safrit J, Ho DD (1995) Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type-1 infection. N Engl J Med 332:201
20. Cheingsong-Papov R, Callow D, Beddows S, et al (1992) Geographic diversity of human immunodeficiency virus type 1: serologic reactivity env epitopes and relationship to neutralization. J Infect Dis 165:256
21. Cheng-Mayer C, Homsy J, Evans LA, Levy JA (1988) Identification of human immunodeficiency virus subtypes and distinct patterns of sensitivity to serum neutralization. Proc Natl Acad Sci USA 85:2815
22. Choppin J, Guillet JG, Levy J-P (1992) HLA class I binding regions of HIV-1 proteins. Criti Rev Immunol 12:1
23. Chow Y-H, Huang W-L, Chi W-K, Chu Y-D, Tao MH (1997) Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 71:169
24. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, Coffman RL, Shearer GM (1994) Role of interleukin-10 in T helper cell dysfunction in asymptotic individuals infected with the human immunodeficiency virus. J Clin Invest 93:768
25. Cohen J (1993) AIDS Research: the mood is uncertain. Science 260:1254
26. Condra JH, Holder DJ, Schleif WA, et al (1996) Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor. J Virolo 70:8270
27. Coney L, Wang B, Ugen KE, Boyer JD, McCallus D, Srikantan V, Agadjanyan MG, Pachuk CJ, Herold K, Merva M, Gilbert L, Dang K, Moelling K, Newman M, Williams WV, Weiner DB (1994) Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo. Vaccine 12:1545
28. Corr M, Lee DJ, Carson DA, Tighe H (1996) Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 184:1555
29. Cullen B, Greene WC (1990) Functions of the auxiliary gene products of the human immunodeficiency virus type 1. Virology 178:1
30. Davis H, Michel ML, Whalen RG (1993) DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet 2:1847
31. De Waal-Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries J (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes
32. Doe B, Selby M, Barnett S, Baenzinger J, Walker CM (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA 93:8578
33. Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081
34. Freeman GJ, Freedman AS, Segil JM, Lee G, Whitman JF, Nadler LM (1989) B7 a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J Immunol 143:2714
35. Fynan E, Webster R, Fuller D, Haynes J, Santoro J, Robinson H (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 90:11478
36. Girard M, Kieny MP, Pinter A, et al (1991) Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc Natl Acad Sci USA 88:542
37. Girard M, Meignier B, Barre-Sinoussi F, Kieny M-P, Matthews T, Muchmore E, Nara PL, Wei Q, Rimsky L, Weinhold K, Fultz PN (1995) Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type-1. J Virol 69:6239
38. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG (1994) Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965
39. Graham B, Wright PF (1995) Candidate AIDS Vaccines. N Engl JMed 333:1331
40. Graham B, Keefer MC, McElrath MJ, Gorse GJ, Schwartz DH, Weinhold K, Matthews TJ, Esterlitz JR, Sinangil F, Fast PE, NIAID AVEG (1996) Safely and immunogenicity of a candidate HIV-1 Vaccine in healthy adults: recombinant (RGP) 120. A randomized, double-blind trial. Ann Intern Med 125:270
41. Groothuis JR (1994) Role of antibody and use of respiratory syncytial virus (RSV) immune globulin to prevent severe RSV disease in high-risk children. J Pediatr 124:S28
42. Guerder S, Carding SR, Flavell RA (1995) B7 co-stimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors. J Immunol 155:5167
43. Hatakeyama M, Tsudo M, Minamoto S, Kono T, Doi T, Miyata T, Miyasaka M, Taniguchi T (1989) Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's. Science 244:551
44. Haynes J, Fuller DH, Eisenbraun MD, Ford MJ, Pertmer TM (1994) AccellÆ particle-mediated DNA immunization elicits humoral, cytotoxic and protective responses. AIDS Res Hum Retroviruses 10:S43
45. He XS, Chen HS, Chu K, Rivkina M, Robinson WS (1996) Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen. Proc Natl Acad Sci USA 93:7274
46. Ho DD (1996) Therapy of HIV infections: problems and prospects. Bull N Y Acad Med 73:37
47. Hohlfeld R, Engel AG (1990) Induction of HLA-DR expression on human myoblasts with interferon-gamma. Am J Pathol 136:503
48. Hohlfeld R, Engel AG (1994) The immunobiology of muscle. Immunol Today 15:269
49. + immune T cells. J Virol 65:220
50. Hsu DH, Moore KW, Spits H (1992) Differential effects of interleukin-4 and -10 on interleukin-2 induced interferon-γ synthesis and lymphokine-activated killer activity. Int Immunol 4:563
51. mac32H(J5). J Virol 69:6289
52. June C, Bluestone JA, Nadler LM, Thompson CB (1994) The B7 and CD28 receptor families. Immunol Today 15:321
53. Katzenstein D, Vujcic LK, Latif A, et al (1990) Human immunodeficiency neutralizing antibodies in sera from North Americans and Africans emergence of neutralization. J Acquir Immune Defic Syndr 3:810
54. Kaye J, Gillis S, Mizel B, Shevach EM, Malek TR, Dinarello CA, Lachman LB, Janeway CA (1984) Growth of a cloned helper T-cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin-1 is required for the expression of receptors for interleukin-2. J Immunol 133:1339
55. Kestler H, Ringler DJ, Mori K, Panicalli DL, Sehgai PK, Daniel MD, Desrosiers RC (1991) Importance of the nef gene for maintenance of high virus loads and tor the development of AIDS. Cell 65:651
56. Kim J, Ayyavoo V, Bagarazzi ML, Chattergoon M, Boyer JD, Wang B, Weiner DB (1997) Development of a multi-component candidate vaccine for HIV-1. Vaccine 15:879-883
57. Kim J, Bagarazzi ML, Hu Y, Trivedi N, Chattergoon MA, Dang K, Agadjanyan MG, Mahalingam S, Boyer JD, Wang B, Weiner DB (1997) Engineering of in vivo immune responses to DNA immunization via co-delivery of costimulatory molecule genes. Nat Biotechn 15:641-645
58. Kim JJ, Ayyvoo V, Bagarazzi ML, Chattergoon MA, Dang K, Wang B, Boyer JD, Weiner DB (1997) In vivo engineering of a cellular immune response by co-administration of IL-12 expression vector with a DNA immunogen. J Immunol 158:816
59. Kim S, Ikeuchi K, Byrn R, Groopman J, Baltimore D (1989) Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 86:9544
60. Koup R, Safrit JT, Cao Y, et al (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type-1 syndrome. J Virol 68:4650
61. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH (1995) B7-1 and B7-2 co-stimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707
62. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M (1995) CD80 (B7) and CD86 (B70) provide similar co-stimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 154:97
63. Levy DN, Fernandes LS, Williams WV, Weiner DB (1993) Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 72:541
64. Levy DN, Refaeli Y, MacGregor RR, Weiner DB (1994) Serum vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 91:10873
65. Levy DN, Refaeli Y, Weiner DB (1994) Extracellular vpr protein increases cellular permissiveness to HIV replication and reactivates virus from latency. J Virol 69:1243
66. Linsley PS, Clark EA, Ledbetter JA (1990) The T cell antigen, CD28, mediates adhesion with B cells by interacting with activation antigen, B7/BB-1. Proc Natl Acad Sci USA 87:5031
67. Lipsky PE, Thompson PA, Rosenwasser LJ, Dinarello CA (1983) The role of interleukin-1 in human B-cell activation: inhibition of B-cell proliferation and the generation of immunoglobulin secreting cells by antibody against human leukocytic pyrogen. J Immunol 130:2709
68. Lu S, Santoro JC, Fuller DH, Haynes JR, Robinson HL (1995) Use of DNAs expressing HIV-1 env and non-infectious HIV-1 particles to raise antibody responses in mice. Virology 209:147
69. Lu S, Arthos J, Montefiori DC, Yasutomi Y, Manson K, Mustafa F, Johnson E, Santoro JC, Wissink J, Mullins JI, Haynes JR, Letvin NL, Wyand M, Robinson HL (1996) Simian immunodeficiency virus DNA vaccine trial in Macaques. J Virol 70:3978
70. Reference deleted
71. MacGregor R, Gluckman S, Lacy K, Kaniefski B, Boyer JD, Wang B, Bagarazzi ML, Williams WV, Francher D, Ginsberg R, Higgins T, Weiner DB (1997) First human trial of a facilitated DNA plasmid vaccine for HIV-1: safety and host response. XI International Conference on AIDS, Vancouver 1:23
72. Malim M, Hauber J, Le SY, Maizel JV, Cullen BR (1989) The HIV-1 rev trans-activator acts through a structured target sequence to activate a nuclear export of unspliced viral mRNA. Nature 338:254
73. + T lymphocytes. J Immunol 155:259
74. Matsumoto S, Matsumoto M, Mita S, Hitoshi Y, Ando M, Araki S, Tominaga A, Takatsu K (1989) IL-5 induces maturation but not class switching of surface IgA-positive B cells into IgA-secreting cells. Immunology 66:32
75. Mogensen SC, Virelizier JL (1987) The interferon-macrophage alliance [Review]. Interferon 8:55
76. Moore MAS (1991) The clinical use of colony stimulating factors. Annu Rev Immunol 9:159
77. Morgan DA, Ruscetti FW, Gallo R (1976) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193:1007
78. Nakane A, Minagawa T, Kato K (1988) Endogenous tumor necrosis factor (cachetin) is essential to host resistance against Listeria monocytigenes infection. Infect Immun 56:2563
79. Nixon D, Townsend AR, Elvin JG, Rizza CR, Gallwey J, McMichael AJ (1988) HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336:484
80. Novembre FJ, Saucier M, Anderson DC, Klumpp SA, O'Neil SP, Brown CR II, Hart CE, Guenthner PC, Swenson RB, McClure HM (1997) Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1. J Virol 71:4086
81. Okamura HHT, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, Torigoe K, Okura T, Nukada Y, Hattori K, Akita K, Namba M, Tanabe F, Konishi K, Fukuda S, Kurimoto M (1995) Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88
82. Okuda K, Bukawa H, Hamajima K, Kawamoto S, Sekigawa K-I, Yamada Y, Tanaka S-I, Ishii N, Aoki I, Nakamura M, Yamamolo H, Cullen BR, Fukushima J (1995) Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Res Hum Retroviruses 11:933
83. + T cell clones. J Immunol 141:849
84. Pantaleo G, Menzo S, Vaccarezza M, et al (1995) Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332:209
85. Pardoll DM, Beckerleg AM (1995) Exposing the immunology of naked DNA vaccines. Immunity 3:165
86. Paul W (1991) Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77:1859
87. Pinto L, Sullivan J, Berzofsky JA, Clerici M, Kessler HA, Landay AL, Shearer GM (1995) Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest 96:867
88. Raz E, Watanabe A, Baird SM, Eisenberg RA, Parr TB, Lotz M, Kipps TJ, Carson DA (1993) Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Natl Acad Sci USA 90:4523
89. Rowland-Jones S, Nixon DF, Aldhous MC (1993) HIV-specific cytoloxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 341:860
90. Rowland-Jones S, Sutton J, Ariyoshi K, Dong T, Gotch F, McAdam S, Whitby D, Sabally S, Allimore A, Corrah T, Takiguchi M, McMichael A, Whittle H (1995) HIV-specific T-cells in HIV-exposed but uninfected Gambian women. Nature Med 1:59
91. Saag M, Hahn BH, Gibbons JH, Li Y, Parks ES, Parks WP, Shaw GM (1988) Extensive variation of human immunodeficiency virus type-1 in vivo. Nature 334:440
92. Schwartz D, Gorse G, Clements ML, Belshe R, Izu A, Duliege A-M, Berman P, Twaddell T, Stablein D, Sposto R, Siliciano R, Matthews T (1993) Induction of HIV-1 neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1(IIIB) rpg120 subunit vaccine. Lancet 342:69
93. Schwartz RH (1992) Costimulation of T lymphocytes: the role of CD29, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065
94. + T cells. Annu Rev Immunol 12:635
95. Sheppard H, Bridges SH, Mathieson BJ, Walker MC, Weinhold K (1994) Conference on Advances in AIDS Vaccine Development-1993 Summary:cCorrelates of HIV immunity working group. AIDS Res Hum Retroviruses 10:S171
96. Sherr C (1990) Colony-stimulating factor-1 receptor. Blood 75:1
97. Strebel K, Dauherty D, Clouse K, Cohen D, Folks T, Martin MA (1987) The HIV "A" (sor) gene product is essential for virus infectivity. Nature 328:728
98. Swain SL, Dutton RW (1982) Production of a B cell growth-promoting activity, (DL)BCGF, from a cloned T cell line and its assay on the BCL1 B cell tumor. J Exp Med 156:1821
99. Tagaya Y, Bamford RN, DeFillipis AP, Waldman TA (1996) A pleiotropic cytokine with diverse receptor signalling pathways whose expression is controlled at multiple levels. Immunity 4:329
100. Tan R, Teh SJ, Ledbetter JA, Linsley PS, Teh HS (1992) B7 costimulates proliferation of CD4-CD8+ T lymphocytes hut is not required for the deletion of immature CD4+CD8+ thymocytes. J Immunol 149:3217
101. Tang D, DeVit M, Johnston S (1992) Genetic immunization is a simple method for eliding an immune response. Nature 356: 152
102. + T cells by B7-transfected melanoma cells. Science 259:368
103. Tracey K, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662
104. Trinchieri G (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate persistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251
105. Ugen K, Boyer JD, Wang B, Gluckman S, Williams WV, Nyland S, Carmack B, Agadjanyan MG, Bagarazzi ML, Higgins T, Coney L, Ciccarelli R, Ginsberg R, MacGregor RR, Weiner DB (1997) Facilitated nucleic acid vaccination of humans with an HIV-1 expressing DNA boosts immune responses against the envelope glycoprotein. In: Brown F, Chanock RM, Ginsberg HS, Norrby E (eds) Vaccines 97: molecular approaches to the control of infectious diseases. Cold Spring Harbor Laboratory Press, Cold Spring Harbor (in press)
106. Ulmer J, Donnelly J, Parker SE, et al (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745
107. Vilcek J, Lee TH (1991) Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions [Review]. J Biol Chem 266:7313
108. Walker BD (1994) The rationale for immunotherapy in HIV-1 infection. J Acquir Immune Defic Syndr 7:S6
109. Wang B, Boyer JD, Srikantan V, Coney L, Carrano R, Phan C, Merva M, Dang K, Agadjanyan MG, Ugen KE, Williams WV, Weiner DB (1993) DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and non-human primates. DNA Cell Biol 12:799
110. Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato A, Boyer J, Williams WV, Weiner DB (1993) Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90:41.56
111. Wang B, Boyer JD, Srikantan V, Ugen KE, Gilbert L, Phan C, Dang K, Merva M, Agadjanyan MG, Newman M, Carrano R, McCallus D, Coney L, Williams WV, Weiner DB (1995) Induction of humoral and cellular immune responses to the human immunodeficiency type-1 virus in non-human primates by in vivo DNA inoculation. Virology 211:102
112. Wang B, Boyer JD, Ugen KE, Srikantan V, Ayyavoo V, Agadjanyan MG, Williams WV, Newman M, Coney L, Carrano R, Weiner DB (1995) Nucleic acid-based immunization against HIV-1: induction of protective in vivo immune responses. AIDS 9:S159
113. Williams TW, Granger GA (1968) Lymphocyte in vitro cytotoxicity: lymphotoxins of several mammalian species. Nature 219:1076
114. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Feigner PL (1990) Direct gene transfer into mouse muscle in vivo. Science. 247:1465
115. WorldBank (1993). Investing in Health. World Development Report 1993. Oxford University Press, Oxford, p 62
116. Xiang Z., Ertl HC (1995) Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129
117. Yocum D, Esparza L, Dubry S, Benjamin J, Volz R, Scuderi P (1989) Characteristics of tumor necrosis factor production in rheumatoid arthritis. Cell Immunol 122:131